|
|
| Countries covered: Europe Research Overview This Frost & Sullivan research service titled European Antidepressants Markets provides a detailed analysis of the antidepressants markets, with a description of key market drivers and restraints. An analysis of the product pipelines of leading companies as well as overall market forecasts are also provided. In this research, Frost & Sullivan’s expert analysts thoroughly examine the following markets: selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), and other antidepressants. Market Sectors Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this research:
Better Efficacy and Relatively Lesser Side-effects of SNRIs to Promote Continued Market Growth The increasing incidence of depression and anxiety disorders in Europe is leading to greater focus on diagnosis and treatment options, thus contributing to the significance of antidepressants. Apart from this, antidepressants are being investigated for their utility in a number of central nervous system (CNS) disorders. As several antidepressants are also being prescribed off-label for a variety of disorders, such as phobias and menopause-related symptoms, among others, continued market developments are expected. Currently, growth in the market is strongly led by the performance of serotonin-norepinephrine reuptake inhibitors (SNRIs), a class of drugs that features limited generic competition and recently introduced brands. Besides, there are a small number of brands outside the selective serotonin reuptake inhibitors (SSRI) and SNRI classes of drugs that are augmenting overall market sales. "In the future, growth in the market is expected to be driven primarily by SNRIs as well as other new classes of antidepressants," says Sumanth Kambhammettu, the analyst of this research service. "This can be attributed to the prevailing perception of greater efficacy and reduced side-effects of SNRIs in comparison to the SSRI class of drugs." Increasing evidence linking SSRIs to instances of suicide among children and adolescents is also hampering the performance of this segment. Moreover, escalating generic competition is anticipated to result in increased market share of SNRIs and other novel antidepressants, thereby affecting the growth of the SSRI class of drugs that currently dominate the market. Effective Product Life-cycle Management Crucial to Combat Intensifying Competition "The maturity of the market, along with increasing parallel importation, reference pricing and rising generic competition are likely to hinder market progress," remarks Mr. Kambhammettu. "In view of surging healthcare costs, most of the European nations have implemented stringent cost -containing measures, resulting in intensifying pressure on profits." Moreover, the implementation of regulatory standards such as the decentralisation of reimbursement policies in Italy and the reimbursement restrictions on certain drugs enforced by majority of the governments in Europe are crucial restraints. Despite these challenges, the high level of unmet clinical needs and the presence of limited innovative drugs, combined with the potential for blockbuster products will continue to drive market expansion. Product life-cycle management will gain prominence and market participants will need to focus on strategically positioning their products early in the life cycle to generate maximum revenues in the patent exclusivity period. Furthermore, research will need to emphasise the expansion of product indications and prolong the life cycles of blockbuster molecules. Establishing marketing collaborations to implement aggressive marketing and product promotion will also become essential to gain a competitive edge in the market. |
More Europe Behavioral Health Reports
Learning Disability, Mental Health & Substance Abuse Facilities in the UK - Industry Market Research Report by
IBISWorld
Learning Disability, Mental Health & Substance Abuse Facilities in the UK Operators in this industry provide residential care to people with learning disabilities, mental illness or ...
NRT Smoking Cessation Aids in Hungary by
Euromonitor International
Tobacco bans have been subject to negotiations between civil organisations, health institutions, cigarette manufacturers and the government for years. As the mortality rate from smoking ...
Plimsoll Portfolio Analysis - Mental Health Centres by
Plimsoll Publishing Ltd.
The Plimsoll Portfolio Analysis - Mental Health Centres is a comprehensive evaluation of the UK market. The revised and updated 2007 edition analyses the financial ...
European Psychotropic Pharmaceutical Markets by
Frost & Sullivan
Antidepressants Beginning to Dominate the Market
Makers of antidepressant drugs can thank doctors for making psychotropic
drugs one of the largest markets in the ...
U.S. and European Markets for Psychotropic Pharmaceuticals by
Kalorama Information
This report from Kalorama Information provides analysis of the dynamic U.S. market for existing and emerging psychotherapeutic drugs. Examines seven primary market segments, anti-anxiety agents, ...
See all reports like this >>
More Europe Reports
A Comprehensive Study Of The UK Video Conferencing Equipment Market In 2010, Rating & Valuing Each Of The 30 Companies That Operate In Today's Market by
Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...
A Comprehensive Study Of The UK Tableware Market In 2010, Rating & Valuing Each Of The 166 Companies That Operate In Today's Market by
Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...
A Comprehensive Study Of The UK Surveyors & Valuers Market In 2010, Rating & Valuing Each Of The 943 Companies That Operate In Today's Market by
Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...
A Comprehensive Study Of The UK Subsea Engineering Market In 2010, Rating & Valuing Each Of The 142 Companies That Operate In Today's Market by
Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...
A Comprehensive Study Of The UK Structural Engineering Consultancy Market In 2010, Rating & Valuing Each Of The 300 Companies That Operate In Today's Market by
Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...
See all reports like this >>
Related Markets
Behavioral Health Reports
- Key Companies: Depression - Leading players must adapt to remain competitive
- CNS Market Access in China - Investment in mental health services offers growth opportunities for psychiatry players
- Product Profiles: Depression - Next generation vies for second-line patients
- Alcohol Addiction Global Clinical Trials Review, Q2, 2011
- Lifestyle Disorders Market to 2016 - Limited Pipeline Products and Slow Progress in R&D are Major Concerns
